Amit Turman
CEO
Claimed by owner Viritis
Former names:
Biological Nanobots for Treating Pathogenic Viruses
Viritis
About
Viritis has developed a new method for treating pathogenic viruses that uses biological nanobots, or virus-like particles, which can enter the human cell, detect whether it has been infected by a pathogenic virus, and then hinder the ability of the virus to hijack the cell mechanism in order to reproduce.
The company’s treatment is suitable for several pathogenic viruses, including influenza, rotavirus, SARS, viruses causing the common cold, and others. The treatment is almost completely side-effect free, can be administrated to patients who are currently sick, and can be used to treat patients with weakened immune systems.
The company’s treatment is suitable for several pathogenic viruses, including influenza, rotavirus, SARS, viruses causing the common cold, and others. The treatment is almost completely side-effect free, can be administrated to patients who are currently sick, and can be used to treat patients with weakened immune systems.
Primary Sector
Life Sciences & HealthTech
Products
-
Geographic markets
-
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
0
Investors
0
News
(0)The Team
(3)Aaron Wis
CFO
AP
Amit Philosoph
Chief Scientist
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Media gallery
(0)Locations
Israel
Nof HaGalil, Israel
Locations
Israel
Nof HaGalil, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,